PTI-125

simufilam · Cassava Sciences, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PTI-125, covering 2021-04-01 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease [Phase 2]